2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EC956
Submitter : Dr. Suzy Kim Date & Time: 10/27/2005 08:10:50
Organization : Dr. Suzy Kim
Category : Health Professional
Issue Areas/Comments
The delay in approving plan b for sale over the counter is deplorable. I think many women could benefit from the immediate availability of this medicine. This would reduce unintended pregnancies and first trimester terminations significantly. Please - no more excuses!